Global Automated Peptide Synthesizer Market Growth 2025-2031

The global Automated Peptide Synthesizer market size is predicted to grow from US$ 588 million in 2025 to US$ 906 million in 2031; it is expected to grow at a CAGR of 7.5% from 2025 to 2031.

Automated Peptide Synthesizer is an instrument used for peptide synthesis according to the principle of solid phase peptide synthesis.

The market for automated peptide synthesizers has experienced significant growth in recent years due to the rising demand for peptides in therapeutics, diagnostics, and research applications. Factors such as the increasing prevalence of chronic diseases, expanding drug discovery and development activities, and advancements in peptide-based therapeutics have positively impacted market growth.

LP Information, Inc. (LPI) ' newest research report, the “Automated Peptide Synthesizer Industry Forecast” looks at past sales and reviews total world Automated Peptide Synthesizer sales in 2024, providing a comprehensive analysis by region and market sector of projected Automated Peptide Synthesizer sales for 2025 through 2031. With Automated Peptide Synthesizer sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Automated Peptide Synthesizer industry.

This Insight Report provides a comprehensive analysis of the global Automated Peptide Synthesizer landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Automated Peptide Synthesizer portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Automated Peptide Synthesizer market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Automated Peptide Synthesizer and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Automated Peptide Synthesizer.

This report presents a comprehensive overview, market shares, and growth opportunities of Automated Peptide Synthesizer market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Single Channel
Multi-channel

Segmentation by Application:
School Laboratory
Biopharmaceutical Company
Synthesis Services Company

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Gyros Protein Technologies AB
Büchi AG
Biotage
CEM
CSBio
AAPPTec
Activotec
MultiSynTech
NJ Biopharmaceuticals LLC
Peptide Machines, Inc.
Protein Technologies, Inc.
Intavis AG
HAINAN JIANBANG PHARMACEUTICAL
Applied Biosystems Inc. (ABI)
Biotage

Key Questions Addressed in this Report

What is the 10-year outlook for the global Automated Peptide Synthesizer market?

What factors are driving Automated Peptide Synthesizer market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Automated Peptide Synthesizer market opportunities vary by end market size?

How does Automated Peptide Synthesizer break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.